查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2023-2030 年合成生物學全球市場
市場調查報告書
商品編碼
1217643

2023-2030 年合成生物學全球市場

Global Synthetic Biology Market - 2023-2030
出版日期: | 出版商: DataM Intelligence | 英文 200 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

市場概覽

工程原理在生物學中的應用是新興的合成生物學跨學科領域的重點。 合成生物學旨在（重新）設計和製造自然界中不存在的生物系統和組件。 合成生物學使研究人員能夠快速創建編目 DNA 序列並組裝新的基因組。 合成生物學將 DNA 的化學合成與不斷擴展的基因組學知識結合起來。 由於 DNA 合成的速度和成本，科學家們現在正在尋找改進的細菌染色體，用於製造改進的生物燃料、生物產品、可再生化學品、生物基特種化學品以及醫療保健行業。現在可以創造

市場動態

推動全球合成生物學市場的主要因素預計將是主要參與者推動市場的戰略投資，以及診斷和技術改進和支持。 由於對蛋白質療法、個性化醫療、合成藥物和疫苗研究等的需求不斷增長，預計該市場將會增長。

預計主要參與者的戰略投資將推動市場增長。

目前，更多的資金分配給製藥公司用於新藥的研發。 補貼各種製藥和生物技術公司的政府計劃正在促進對營養補充劑和冥想的研究。

如果社會對合成生物學的看法發生變化，合成生物學產品的市場將會興起。 因此，市場參與者正在通過收購和聯合研究等活動投資於戰略發展，以發展他們的公司並滿足需求。 例如，SynBio Innovation Accelerator 於 2020 年 11 月由領先的合成生物學初創公司 Codexis, Inc. 和知名生命科學投資者 Casdin Capital 共同推出。 日本巨頭住友化學在美國成立了一家名為 SynBio Hub 的新公司，旨在培育基於合成生物學的下一代業務。

合成生物學初創公司在 2020 年投資了 78 億美元，到 2021 年達到 180 億美元。 DNA Script 和 Arbor Biotechnologies 等公司分別籌集了約 2.15 億美元和 1.672 億美元。 大筆投資促進了資金在市場中的流動，並有助於擴大供應鏈上的業務。

市場擴張可能會因安全問題而受阻。

但是，有意或無意地將轉基因生物釋放到環境中會對人類和生態系統產生不利影響。 因此，預計市場擴張將受阻。

COVID-19 影響分析

由於 COVID-19 的爆發，合成生物學產品的使用在過去兩年中有所擴大。 借助創建 COVID-19 檢測試劑盒、治療和免疫接種的新方法，許多領先的製藥和生物技術公司以及合成生物學行業參與者正在全球範圍內加緊研究工作。 根據歐洲議會的一項研究，合成生物學是新興技術之一。 它可以應用於針對 COVID-19 傳染病的措施。 美國國立衛生研究院正在考慮使用合成生物學來加快疫苗的研製。

合成生物學正在從一項基本的學術努力演變為一項已部分工業化的可靠戰略。 在 COVID-19 大流行期間，合成生物學的生物醫學潛力從未如此明顯。 從研究的進步到疫苗、療法和診斷學的快速發展，該領域正在為全球災難做出重大貢獻。 使許多合成生物學過程自動化，例如 DNA 和 RNA 的合成，對於推進這一重要領域至關重要。 為了利用合成生物學的發展勢頭並將其優勢擴展到癌症、代謝病和遺傳病等傳染病以外的領域，有必要改進當前的自動化平台，並且仍然需要手動完成。步驟自動化應該繼續下去。

內容

第一章研究方法與範圍

  • 調查方法
  • 調查目的和範圍

第 2 章市場定義和概述

第 3 章執行摘要

第四章市場動態

  • 市場影響因素
    • 司機
      • 預計主要公司將進行戰略投資以推動市場發展。
      • 通過診斷和技術改進提供支持
    • 約束因素
      • 安全問題很可能會阻礙市場擴張。
    • 機會
    • 影響分析

第五章行業分析

  • 波特的五力分析
  • 供應鏈分析
  • 定價分析
  • 監管分析

第 6 章 COVID-19 分析

  • COVID-19 市場分析
    • COVID-19 之前的市場情景
    • COVID-19 的當前市場情景
    • COVID-19 後或未來情景
  • COVID-19 期間的價格動態
  • 供需範圍
  • 大流行期間與市場相關的政府舉措
  • 製造商的戰略舉措
  • 總結

第 7 章按產品類型

  • 核心產品
    • 合成基因
    • 合成DNA
    • 合成細胞
    • 底盤生物
    • 其他
  • 可行的產品
    • 寡核甘酸合成
    • DNA合成

第八章技術

  • 基因合成
  • 基因組工程
  • 核甘酸測序
  • 生物信息學
  • 克隆
  • 定點誘變
  • 測量和建模
  • 微流體

第 9 章按應用

  • 醫療保健
  • 食品和農業
  • 化學品
  • 其他

第10章按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 意大利
    • 西班牙
    • 其他歐洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 其他亞太地區
  • 中東和非洲

第11章競爭格局

  • 主要發展和戰略
  • 公司股票分析
  • 產品基準
  • 值得關注的主要公司名單

第12章公司簡介

  • 阿米瑞斯公司
    • 公司概況
    • 產品組合和說明
    • 主要亮點
    • 財務摘要
  • Algenol Biofuels Inc.
  • Bayer AG
  • CBC Comprehensive Biomarker Center GmbH
  • Bristol-Myers Squibb
  • Biosearch Technologies Inc.
  • Gene Script Corporation
  • GeneWorks Pty Ltd.
  • DuPont Inc.
  • Thermo Fisher Scientific In.

第13章 DataM

簡介目錄
Product Code: DMBT2364

Market Overview

The global synthetic biology market size was valued at US$ XX million in 2022 and is estimated to reach US$ XX million by 2030, growing at a CAGR of XX% during the forecast period (2023-2030).

The application of engineering principles to biology is the focus of the emerging interdisciplinary field of synthetic biology. It aspires to create biological systems and parts that do not already exist in the natural world through (re-)design and fabrication. With the help of synthetic biology, researchers can quickly produce cataloged DNA sequences and assemble them into new genomes. Synthetic biology combines the chemical synthesis of DNA with expanding genomics knowledge. Scientists are now able to create modified bacterial chromosomes that can be employed in manufacturing improved biofuels, bioproducts, renewable chemicals, and bio-based specialty chemicals, as well as in the healthcare industry, due to advancements in the speed and cost of DNA synthesis.

Market Dynamics

The major factors driving the global synthetic biology market the key companies are anticipated to make strategic investments to drive the market, improved diagnosis and techniques to support. The market is anticipated to rise in response to the rising demand for protein therapies, individualized medicine, and research into synthetic drugs and vaccines.

Key companies are anticipated to make strategic investments is expected to drive the market's growth.

More funding is now being allocated to pharmaceutical companies for research and development to find new medications. Government programs subsidizing various pharma and biotech companies have promoted research into dietary supplements and meditation.

The market for synthetic biology products rises as societal perceptions of synthetic biology change. As a result, major market players invest in strategic development through activities like acquisition, collaboration, etc., to grow their companies and meet demand. For instance, the SynBio Innovation Accelerator was introduced by premier synthetic biology start-up Codexis, Inc. and a renowned life science investor, Casdin Capital, in November 2020. One of the major players in Japan, Sumitomo Chemical, established SynBio Hub, a new company in the U.S., intending to foster the development of synthetic biology-based next-generation businesses.

In 2020, investments in start-ups in the synthetic biology industry totalled $7.8 billion, and in 2021, they reached $18.0 billion. Companies like DNA Script and Arbor Biotechnologies raised about 215 million and 167.2 million dollars, respectively. The significant investment promotes the flow of money through the market and aids in the expansion of businesses along the supply chain.

The market's expansion will likely be hampered by safety concerns.

However, the intentional or unintentional release of genetically modified organisms into the environment could have detrimental effects on the health of both people and the ecosystem. In consequence, it is anticipated that this will impede market expansion.

COVID-19 Impact Analysis

The use of synthetic biology products has expanded during the last two years due to the COVID-19 outbreak. By using novel methods for creating test kits, treatments, and vaccinations for COVID-19, many major pharmaceutical and bioTechnologies businesses and synthetic biology industry participants have intensified their research operations globally. Synthetic biology is one of the emerging technologies, according to a study from the European Parliament. It can be applied to the fight against COVID-19 infection. The National Institute of Health in the U.S. has also highlighted the use of synthetic biology to hasten the creation of vaccines.

Synthetic biology has evolved from a rudimentary academic endeavor to a solid, partially industrialized strategy. During the COVID-19 pandemic, the biomedical opportunities provided by synthetic biology have never been more apparent: from advancing research to enabling quicker development of vaccines, therapeutics, and diagnostics, this discipline has made great contributions during a worldwide catastrophe. Automating the many synthetic biology processes, such as DNA and RNA synthesis, has been crucial to developing this significant field. Building on the momentum of synthetic biology and extending its advantages to areas beyond infectious diseases, such as cancer, metabolic, and genetic disorders, companies would need to improve the present automation platforms and carry on with the automation of stages that are still done manually.

Segment Analysis

The healthcare segment is expected to grow at the fastest CAGR during the forecast period (2023-2030)

The application segment is the highest market holder in the global synthetic biology market. The quick advancement of synthetic biology has driven the healthcare segment in terms of the various treatment techniques utilizing designed phages, artificial cells, and live bacteria.

For instance, it has made it possible for life technologies to create antigens and variants with high expression, quick outcomes, and capacity. Applications for synthetic biology range from the creation of drugs and vaccines to the production of products and diagnostic procedures.

Researchers use rational engineering methods to create unique, dynamic biosensing systems composed of a processor, sensor, and reporter. A growth in neurological diseases like multiple sclerosis is also fueling this market. For instance, starting in July 2022, synthetic biology specialists at the University of Toronto Engineering are creating personalized stem cells from patient tissues to treat ailments. These research initiatives are expected to support segment growth. Additionally, several initiatives performed by governments and other organizations are anticipated to benefit the market for research in this segment.

Geographical Analysis

North America holds the largest market share in the global synthetic biology market.

North America dominates the global Synthetic Biology market primarily due to its large population, excellent medical infrastructure, and high-income levels. Due to the expanding demand for bio-based products, rising investments in synthetic biology businesses, and rising R&D funding for synthetic biology, North America is predicted to have the greatest proportion of the global market for synthetic biology. as a result of greater government support, favorable laws, and increased investment in the development of synthetic biological products. In the first half of 2020, businesses in this industry, including Moderna Therapeutics, Sana BioTechnologies, Poseida Therapeutics, Apeel Sciences, and Greenlight Biosciences, raised more than $3 billion in financing.

Proteomics, genomic structure prediction, and drug development research are highly valued in the U.S., which is good for the synthetic biology sector. Additionally, certain for-profit businesses like the Gates and Melinda Foundation and government-funded research institutions like the National Institutes of Health (NIH) are promoting synthetic biology research and development, which could improve the chances for the nation's economic development. Additionally, growing funding from public and private organizations and R&D expenditures on drug development are significant growth factors anticipated to propel the market throughout the forecast period.

Competitive Landscape

The Synthetic Biology market is moderately competitive with local and global companies' presence Amyris Inc., Algenol Biofuels Inc., Bayer AG, CBC Comprehensive Biomarker Center GmbH, Bristol-Myers Squibb, Biosearch Technologies Inc., Gene Script Corporation, GeneWorks Pty Ltd., DuPont Inc., Thermo Fisher Scientific In and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in July 2021, addition to announcing the expansion of their research partnership, Codexis, Inc. and Kalsec, Inc. also signed a unique supply arrangement for a novel enzyme that will be used to create Kalsec's newest natural hop acid.

Thermo Fisher Scientific Inc.

Overview: In order to meet the demands of difficult analytical problems in research, diagnostics, and clinical laboratories, Thermo Fisher Scientific Inc. (Thermo Fisher) offers medical equipment, analytical instruments, reagents and consumables, software, and services. It provides answers for flow cytometry, synthetic biology, and cellular biology. The company offers a variety of goods, including as technologies for protein and molecular biology research, electron microscopy, mass spectrometry, and genetic sequencing. The business provides services to academic and research institutions, government agencies, pharmaceutical and biotech firms, clinical diagnostic laboratories, environmental, industrial quality, and process control sectors.

Product Portfolio:

Invitrogen GeneArt Gene Synthesis Services: Getting unique DNA constructions with 100% sequence fidelity is easy and affordable with GeneArt Custom Gene Synthesis. The company offers optimization using the patented GeneOptimizer algorithm, which uses a special multifactorial strategy that goes beyond codon optimization, to maximize the expression of synthetic genes.

The global Synthetic Biology market report would provide access to approx.: 45+ market data table, 40+ figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Key companies are anticipated to make strategic investments to drive the market.
      • 4.1.1.2. Improved diagnosis and techniques to support.
    • 4.1.2. Restraints:
      • 4.1.2.1. The market's expansion will likely be hampered by safety concerns.
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Core Product
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
      • 7.2.2.1. Synthetic Genes
      • 7.2.2.2. Synthetic DNA
      • 7.2.2.3. Synthetic Cells
      • 7.2.2.4. Chassis Organisms
      • 7.2.2.5. Others
  • 7.3. Enabling Product
      • 7.3.1.1. Oligonucleotide Synthesis
      • 7.3.1.2. DNA Synthesis

8. By Technologies

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
    • 8.1.2. Market Attractiveness Index, By Technologies
  • 8.2. Gene Synthesis
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 8.3. Genome Engineering
  • 8.4. Sequencing
  • 8.5. Bioinformatics
  • 8.6. Cloning
  • 8.7. Site-Directed Mutagenesis
  • 8.8. Measurement & Modeling
  • 8.9. Microfluidics

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Healthcare
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030
  • 9.3. Food & Agriculture
  • 9.4. Chemicals
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis US$ Million, 2021-2030 and Y-o-Y Growth Analysis (%), 2022-2030, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Technologies
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Products Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Amyris Inc
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Algenol Biofuels Inc.
  • 12.3. Bayer AG
  • 12.4. CBC Comprehensive Biomarker Center GmbH
  • 12.5. Bristol-Myers Squibb
  • 12.6. Biosearch Technologies Inc.
  • 12.7. Gene Script Corporation
  • 12.8. GeneWorks Pty Ltd.
  • 12.9. DuPont Inc.
  • 12.10. Thermo Fisher Scientific In.

LIST NOT EXHAUSTIVE

13. Global Synthetic Biology Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and Application
  • 13.3. Contact Us